Results 61 to 70 of about 42,722 (256)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1205-1215, May 2026.
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco   +17 more
wiley   +1 more source

Factors Affecting Visual Recovery in Patients with Ethambutol-Induced Optic Neuropathy

open access: yesClinical Ophthalmology, 2023
Supaporn Srithawatpong,1,2 Pareena Chaitanuwong,1,2 Yosanan Yospaiboon3 1Department of Ophthalmology, Rajavithi Hospital, Ministry of Public Health, Bangkok, Thailand; 2Department of Ophthalmology, College of Medicine, Rangsit University, Bangkok ...
Srithawatpong S   +2 more
doaj  

Treatment of tuberculosis in a region with high drug resistance: Outcomes, drug resistance amplification and re-infection [PDF]

open access: yes, 2011
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods: We combined drug susceptibility results and molecular strain typing data with treatment outcome ...
Andrew, P W   +16 more
core   +2 more sources

Clinical Images: A thorn injury, a sea‐borne culprit, and a tenosynovitis dilemma

open access: yes
Arthritis &Rheumatology, EarlyView.
Jacopo Ciaffi   +8 more
wiley   +1 more source

Case Report of an Infectious Aortic Aneurysm Following Intravesical Bacillus Calmette‐Guérin Therapy After Transurethral Resection of a Bladder Tumor

open access: yesIJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Intravesical Bacillus Calmette‐Guérin (BCG) therapy is an established treatment for non‐muscle‐invasive bladder cancer. Although systemic BCG infection is rare, infectious aortic aneurysm is a potentially fatal complication.
Daisuke Muto   +9 more
wiley   +1 more source

Concurrent Bladder Urothelial Carcinoma and Prostate Tuberculosis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Tuberculosis is associated with an increased risk of bladder cancer; however, the simultaneous occurrence of urogenital tuberculosis and bladder cancer is rare. Primary prostate tuberculosis is relatively uncommon in patients with urogenital tuberculosis.
Rikuo Suzuki, Taketo Kawai
wiley   +1 more source

Study of the pharmacokinetics of antituberculosis drug Biomairin

open access: yesФармакокинетика и Фармакодинамика, 2018
Resume. The results of a studying the pharmacokinetics of the anti-tuberculosis drug Biomayrin in experimental animals (rats) after oral administration were presented. A comparative analysis of the pharmacokinetic parameters of Biomayrin with a comparing
Sh. A. Shomurotov   +6 more
doaj   +1 more source

3PC-023 Patch tests with ethambutol 10%, isoniazid 15% and pyrazinamide 25%: a case report [PDF]

open access: gold, 2023
Clara Lemos de Faria Leitão   +4 more
openalex   +1 more source

Losartan API and Nitrosamines Impurities—Stability Profile Investigation Using HPLC, LC‐MS, and In Silico Assessment

open access: yesJournal of Separation Science, Volume 49, Issue 5, May 2026.
ABSTRACT Nitrosamines are potent genotoxic impurities with well reported mutagenic and carcinogenic effects. Their presence has been detected in several pharmaceutical products among them losartan, an angiotensin II receptor blocker. Considering the risks already reported for these impurities, the present study aimed to investigate the influence of ...
Paulo Roberto Rodrigues Martini   +6 more
wiley   +1 more source

Rapidly developing Optic Neuritis secondary to Ethambutol: possible mechanism of injury [PDF]

open access: yes, 2005
Optic neuritis has been described among the toxic effects of Ethambutol. This side effect is dose related. The mean duration of Ethambutol induced optic neuritis (EON) is three months.
Ali, Sajjad   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy